A new study published in Cancer Discovery highlights an imp…
A new study published in Cancer Discovery highlights an important gap in cancer genetics.
🔬 Key findings from 39,184 patients with solid tumours:
16.3% had at least one inherited pathogenic gene variant.
Restricting testing to patients diagnosed before age 50 would have missed 72% of patients identified with these variants.
Identifying inherited variants can help inform treatment decisions and enable family members to assess their own hereditary cancer risk.
The takeaway: Age alone may be an insufficient criterion for germline genetic testing. Broader testing strategies could help identify more patients and families who may benefit from genetic risk assessment. https://www.aacr.org/about-the-aacr/newsroom/news-releases/current-age-based-genetic-testing-in-patients-with-cancer-may-miss-majority-of-inherited-gene-variants/
www.aacr.org
Current Age-based Genetic Testing in Patients With Cancer May Miss Majority of Inherited Gene Variants
A new study published in the AACR journal Cancer Discovery suggests that all patients with cancer, regardless of age, should be screened for inherited genetic variants associated with cancer—not just patients under age 50, as is typically done.
0 likes · 0 comments · 1 views